Identification of biomarkers for prognosis of morbidity and mortality of SARS-CoV-2 (COVID-19) patients

Identification of biomarkers for prognosis of morbidity and mortality of SARS-CoV-2 (COVID-19) patients - COVID-19 biomarker

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023322

Enrollment

250

Registered

2020-10-19

Start date

2020-04-09

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J12.8

Interventions

Group 1: COVID-19 patients (measurement of biomarkers at the beginning of the disease and during the course of the disease)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: confirmed COVID-19 infection

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Early detection of severe course of SARS-CoV-2 (COVID-19) patients	—

Countries

France, Germany

Contacts

Public ContactPhil-Robin Tepasse

Universitätsklinikum Münster Medizinische Klinik B (Gastroenterologie, Hepatologie, Endokrinologie, Medizinische Infektiologie)

phil-robin.tepasse@ukmuenster.de0251-83-44882

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026